Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Aimmune Therapeutics

FARE Launches Global Research Competition to Develop a Safe, Compassionate Diagnostic...

Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...

Nestlé to Acquire Aimmune Therapeutics

Study Shows Negative Impact of Avoidance and Fear of Accidental Reactions...

New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...

FDA Approves Aimmune’s PALFORZIA as First Treatment for Peanut Allergy

FAQ for Palforzia, the First FDA Approved Therapy for Food Allergy

Follow Us

Your School On Our Map

Put Your School on the Map